Q. Zhang
-
- HER2/EGFR in Cancer Research 8
- Cancer Treatment and Pharmacology 6
- Cancer Immunotherapy and Biomarkers 4
- Lung Cancer Research Studies 4
- CAR-T cell therapy research 2
-
- Advanced Breast Cancer Therapies 6
-
- Monoclonal and Polyclonal Antibodies Research 7
-
- Biosimilars and Bioanalytical Methods 5
- Partner nations
- ChinaSwitzerlandUnited Kingdom
In The Last Decade
Q. Zhang
25 papers receiving 255 citations
Peers
Comparison fields: 5 of 45
- Oncology 164
- Otorhinolaryngology 20
- Pathology and Forensic Medicine 73
- Pulmonary and Respiratory Medicine 110
- Cancer Research 34
Countries citing papers authored by Q. Zhang
This map shows the geographic impact of Q. Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Q. Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Q. Zhang more than expected).
Fields of papers citing papers by Q. Zhang
This network shows the impact of papers produced by Q. Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Q. Zhang. The network helps show where Q. Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Q. Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 43 | |
| 9 | 2022 | 14 | |
| 10 | 2020 | 7 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 1 | |
| 13 | 2019 | 2 | |
| 14 | 2019 | 40 | |
| 15 | 2018 | 1 | |
| 16 | 2018 | 2 | |
| 17 | 2018 | 4 | |
| 18 | 2018 | 3 | |
| 19 | 2018 | 1 | |
| 20 | 2010 | 93 |
About Q. Zhang
Q. Zhang is a scholar working on Oncology, Otorhinolaryngology and Radiology, Nuclear Medicine and Imaging, having authored 27 papers that have together received 272 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Advanced Breast Cancer Therapies (6 papers), Cancer Treatment and Pharmacology (6 papers), Biosimilars and Bioanalytical Methods (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Research Studies (4 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Oncology (164 citations), Otorhinolaryngology (20 citations) and Pathology and Forensic Medicine (73 citations). Q. Zhang has collaborated with scholars based in China, Switzerland and United Kingdom. Frequent co-authors include Xinmei Kang, Xiao‐Jun Huang, Jin Shi, Dabei Tang, Yuwei Deng, Jianqun Ma, W. Li, Zbigniew Nowecki, S.-B. Kim and Alberto J. Montero. Their work appears in journals such as Annals of Oncology, Life Sciences and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.